Company overview

Teva Pharmaceutical Industries (Teva) is the world's leading generic pharmaceutical company. It is engaged in the development, production and marketing of generic, proprietary branded pharmaceuticals and active pharmaceutical ingredients. Teva further enhanced its leadership position in the US generic market by completing the acquisition of Barr Pharmaceuticals, a US based multinational generic pharmaceutical company, for $7.5 billion in December 2008.

The company conducts its global operations in North America, Europe, Latin America, Asia and Israel. Teva is headquartered in Petach Tikva, Israel and employed 38,307 people as of December 2008.

The company recorded revenues of $11,085 million during the financial year (FY) ended December 2008, an increase of 17.8% over FY2007. The operating profit of the company was $1,145 million during FY2008, a decrease of 52.2% over FY2007. The net profit was $635 million in FY2008, a decrease of 67.5% over FY2007.

Key facts

NASDAQ National Market ticker: TEVA

Tel Aviv ticker: TEVA

No. employees: 38307

Turnover: 11,085,000,000 (USD)

Financial year end: December

Summary

• Key facts
• Overview
• Business Description
• History
• Key Employees and Biographies
• Location and Subsidiaries
• Top Competitors
• Major Products and Services

SWOT Profiles

This SWOT analysis company profile is the essential source for top level data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Scope of this research

• Provides all the crucial company information required for business and competitor intelligence needs.
• Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams.
• Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Key reasons to purchase this research

• Support sales activities by understanding your customers' businesses better
• Qualify prospective partners and suppliers
• Keep fully up to date on your competitors' business structure, strategy and prospects
• Obtain the most up to date company information available